Document is current
Any future updates will be listed below
-
Authors
Vanderpuye, Verna http://orcid.org/0000-0003-3656-6965
Hammad, Nazik
Martei, Yehoda
Hopman, Wilma M.
Fundytus, Adam
Sullivan, Richard
Seruga, Bostjan
Lopes, Gilberto
Sengar, Manju
Brundage, Michael D.
Booth, Christopher M.
- License Information
-
More Information
Article History
Received: 2 November 2018
Accepted: 10 April 2019
First Online: 21 May 2019
Ethics approval and consent to participate
: Ethics approval was obtained by the REB at Queen’s University, Kingston, Canada.
: not applicable.
: Richard Sullivan.Honoraria: Pfizer.Consulting or Advisory Role: Pfizer (Inst).Bostjan Seruga.Honoraria: Astellas Pharma, Janssen Oncology, Novartis, Sanofi.Consulting or Advisory Role: Astellas Pharma, Sanofi, Janssen Oncology.Gilberto Lopes.Honoraria: AstraZeneca, Roche/Genentech, Merck Serono, Merck Sharp & Dohme, Fresenius Kabi, Novartis, Bristol- Myers Squibb, Janssen-Cilag, Boehringer Ingelheim, Pfizer, CIPLA, Sanofi, Eisai, Eli Lilly.Consulting or Advisory Role: Pfizer, Bristol-Myers Squibb, Eli Lilly/ImClone.Research Funding: Eli Lilly/ImClone, Pfizer, AstraZeneca, Merck Sharp & Dohme, Eisai, Bristol-Myers Squibb Expert Testimony: Sanofi.The other authors have no disclosures.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
